amides - CISMeF

Preferred Label : amides;

MeSH definition : Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed);

MeSH synonym : Amide;

Wikipedia link : https://en.wikipedia.org/wiki/Amide;

Is substance : O;

Details

Origin ID

D000577;

UMLS CUI

C0002482;

ATC code(s)
- amides [ATC Code]
- synthetic antispasmodics, amides with tertiary amines [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Amidation [NCIt concept]
- Amide (substance) [SNOMED CT concept]
- amide, nos [SNOMED Notion]
- amides [ATC Code]
- amides [IUPAC Term]
Record concept(s)
- amides [MeSH concept]
Related MeSH Supplementary Concept(s)
- ((O,O-diacetyl)-L-dopa-methylester)succinyldiamide [MeSH Supplementary Concept]
- (2E)-N-(1,3-benzothiazol-2-yl)-3-(2,5-dimethoxyphenyl)-2-propenamide [MeSH Supplementary Concept]
- (2R,3S)-6,6,6-trifluoro-3-(formyl(hydroxy)amino)-2-isobutyl-N-((1S,2R)-2-methoxy-1-((1,3-thiazol-2-ylamino)carbonyl)propyl)hexanamide [MeSH Supplementary Concept]
- (2R,3Z)-N-(1-hydroxyoctadec-3-en-2-yl)pivalamide [MeSH Supplementary Concept]
- (3R)-3-(3,4-dichlorophenyl)-N-((1R)-1-(4-(4,5-dihydro-1H-imidazol-2-yl)benzyl)-(2-oxo-2-pyrrolidin-1-ylethyl)-3-(2-naphthylsulfonyl)amino)propanamide [MeSH Supplementary Concept]
- (5-chloro-2(3H)-benzoxazolon-3-yl) propanamide [MeSH Supplementary Concept]
- (E)-3-hydroxy-2,4-dimethylhept-4-enamide [MeSH Supplementary Concept]
- (E)-N-(4-methoxyphenethyl)-2-methylbut-2-enamide [MeSH Supplementary Concept]
- (O,O-diacetyl)-L-Dopa-methylester fumaric diamide [MeSH Supplementary Concept]
- (O,O-diacetyl)-L-Dopa-methylester maleic diamide [MeSH Supplementary Concept]
- (R)-(11C)1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide [MeSH Supplementary Concept]
- (R)-1-(1-(1-(ethylsulfonyl)piperidin-4-yl)ethyl)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1H-indole-3-carboxamide [MeSH Supplementary Concept]
- (R)-4'-(1-fluoro-1-methyl-2-(propane-2-sulfonylamino)-ethyl)-biphenyl-4-carboxylic acid methylamide [MeSH Supplementary Concept]
- (R,E)-N-(1-hydroxy-4-(tridecylthio)but-3-en-2-yl)octanamide [MeSH Supplementary Concept]
- (R,E)-N-(1-hydroxy-4-(tridecylthio)but-3-en-2-yl)pivalamide [MeSH Supplementary Concept]
- (S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamide) [MeSH Supplementary Concept]
- 1,1-difluoro-3-hexadecanamido-2-(5-hydroxypentyl)-4-phenylbutanephosphonic acid [MeSH Supplementary Concept]
- 1,2-bis(dodecylamido)cyclohexane [MeSH Supplementary Concept]
- 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-n-(4-(p-maleimidophenyl)butyramide) [MeSH Supplementary Concept]
- 1,3-bis(N-2-(hydroxyethyl)lauroylamino)-2-hydroxypropane [MeSH Supplementary Concept]
- 1,3-dioxoisoindoline-5-carboxamide [MeSH Supplementary Concept]
- 1-(1-(4-fluoro-2-(2-oxopyrrolidin-1-yl)phenyl)-3-oxopiperidin-4-ylcarbamoyl)cyclohexyl furan-2-carboxylic acid amide [MeSH Supplementary Concept]
- 1-(13-(3',4'-methylenedioxyphenyl)-2E,4E,12E-tridecatrienoyl)-N-isopentylamide [MeSH Supplementary Concept]
- 1-(2-methoxyphenyl)piperazine amide [MeSH Supplementary Concept]
- 1-(3-1,2,4-Nitrotriazole-1-yl)-propanhydroxyiminoamide [MeSH Supplementary Concept]
- 1-(4-(2-hydroxyethyl)piperazin-1-yl)-3,3-diphenylpropan-1-one [MeSH Supplementary Concept]
- 1-(6-nitrobenzoimidazole-1-yl)-propanhydroxyiminoamide [MeSH Supplementary Concept]
- 1-ethyl-3-methyl-imidazolium dicyanoamide [MeSH Supplementary Concept]
- 11-(2,4-dinitro-5-fluorobenzene)undecenamide [MeSH Supplementary Concept]
- 11-(3-hydroxy-6-pentylphenoxy)undecanoic acid cyclopropylamide [MeSH Supplementary Concept]
- 11-(5-hydroxy-2-pentylphenoxy)undecanoic acid cyclopropylamide [MeSH Supplementary Concept]
- 2,2'-(N,N'-oxalyldiimino)bis(3-phenylpropanamide) [MeSH Supplementary Concept]
- 2,2'-azobis(N-(2-carboxyethyl)-2-methylpropionamidine) tetrahydrate [MeSH Supplementary Concept]
- 2,2,3,3-tetramethylcyclopropane carboxamide [MeSH Supplementary Concept]
- 2,3-dihydroxypropionamide [MeSH Supplementary Concept]
- 2,3-dihydroxyterephthalamide [MeSH Supplementary Concept]
- 2,3-epoxy-4-oxononadecanamide [MeSH Supplementary Concept]
- 2,3-epoxy-4-oxotridecanamide [MeSH Supplementary Concept]
- 2,6-diethylamidopyridine [MeSH Supplementary Concept]
- 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide [MeSH Supplementary Concept]
- 2-(3,4-dihydroxypyrrolidin-1-yl)-3-methylbutyramide [MeSH Supplementary Concept]
- 2-(4-fluoro-3-(trifluoromethyl)phenoxy)-N-(phenylmethyl)butanamide [MeSH Supplementary Concept]
- 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-, (2R)- [MeSH Supplementary Concept]
- 2-N-(2'-s-triphenylmethylacetyl)amino-(N'-2''-N,N''-dimethylethylamine)butyramide [MeSH Supplementary Concept]
- 2-N-(2'-s-triphenylmethylacetyl)amino-3-methyl-(N'-2''-N,N''-dimethylethylamine)butyramide [MeSH Supplementary Concept]
- 2-chloropropionamide [MeSH Supplementary Concept]
- 2-ethyl-5-methylhexanamide [MeSH Supplementary Concept]
- 2-ethylpentanamide [MeSH Supplementary Concept]
- 2-hydroxy-2-(4'-chlorophenyl)butyramide [MeSH Supplementary Concept]
- 2-hydroxy-2-phenylnonanamide [MeSH Supplementary Concept]
- 2-hydroxy-N-(2-hydroxyphenyl)propionamide [MeSH Supplementary Concept]
- 2-isovaleramidobut-2-enoic acid [MeSH Supplementary Concept]
- 2-methoxy-2-phenyl-2-trifluoromethyl-N-alpha-methyl benzyl propanamide [MeSH Supplementary Concept]
- 2-methoxyisophthalamide [MeSH Supplementary Concept]
- 2-methylbutyramide [MeSH Supplementary Concept]
- 2-phenylpropionamide [MeSH Supplementary Concept]
- 3(4-butoxyphenyl)propionamide [MeSH Supplementary Concept]
- 3,4-diphenyl-imidazol-2-one-1-carboxylic acid phenyl amide [MeSH Supplementary Concept]
- 3,7,11-trimethyldodeca-2,6,10-trienoic acid hexadecylamide [MeSH Supplementary Concept]
- 3-(3-fluoro-4-chlorophenoxy)-N-(4-cyano-3-trifluoromethylphenyl)-2-hydroxy-2-methylpropionamide [MeSH Supplementary Concept]
- 3-(4-dimethylaminophenyl)-N-hydroxy-2-propenamide [MeSH Supplementary Concept]
- 3-(4-fluorophenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)propanamide [MeSH Supplementary Concept]
- 3-(4-hydroxyphenyl)-N-benzylpropionamide [MeSH Supplementary Concept]
- 3-OH-ropivacaine [MeSH Supplementary Concept]
- 3-aminopicolinamide [MeSH Supplementary Concept]
- 3-chloropropionamide [MeSH Supplementary Concept]
- 3-ethylamino-2-(4-nitro-benzoyl)-but-2-enoic acid phenylamide [MeSH Supplementary Concept]
- 3-hydroxy-3-(4'-chlorophenyl)pentanamide [MeSH Supplementary Concept]
- 3-hydroxy-3-phenylpentamide [MeSH Supplementary Concept]
- 3-pyrimidin-5-ylpropanamide [MeSH Supplementary Concept]
- 3-sulfonyltridecanamide [MeSH Supplementary Concept]
- 4'-aminomethyl-N,N'-trimethylenedibenzohydroxamamide [MeSH Supplementary Concept]
- 4,5-dihydropiperlonguminine [MeSH Supplementary Concept]
- 4-((2-oxododecanoyl)amino)octanoic acid [MeSH Supplementary Concept]
- 4-(2-(1-methylethyl)phenyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide [MeSH Supplementary Concept]
- 4-(2-acetoxybenzoylamino)butyramide [MeSH Supplementary Concept]
- 4-(2-dimethylaminophenyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide [MeSH Supplementary Concept]
- 4-(2-diphenyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide [MeSH Supplementary Concept]
- 4-(dodecanoylamino)decan-5-ol [MeSH Supplementary Concept]
- 4-aminobutanamide [MeSH Supplementary Concept]
- 4-hydroxy-4-(4'-chlorophenyl)hexanamide [MeSH Supplementary Concept]
- 4-methyl-2-(naphthalen-2-yl)-N-propylpentanamide [MeSH Supplementary Concept]
- 4-methyl-3-phenylcarbamoyl-1,2,5-selenadiazole [MeSH Supplementary Concept]
- 5-amino-4-hydroxy-7-(4-methoxy-3-(3-methoxypropyl)benzyl)-2,8-dimethylnonanoic acid butylamide [MeSH Supplementary Concept]
- 5-aza-6-cyclohexylmethyl-3-cyclohexylpropyl-4,7-dioxo-7-(phenylethylamino)heptanohydroxamic acid [MeSH Supplementary Concept]
- 5-aza-6-cyclohexylmethyl-4,7-dioxo-7-(phenylethylamino)-3-phenylpropylheptanohydroxamic acid [MeSH Supplementary Concept]
- 5-chloroindoloyl glycine amide [MeSH Supplementary Concept]
- 5-cyanovaleramide [MeSH Supplementary Concept]
- 5-oxopyrrolidine-3-carboxamide [MeSH Supplementary Concept]
- 5F-CUMYL-PICA [MeSH Supplementary Concept]
- 6-(ethyl-(2-methoxybenzyl)amino)hexanoic acid (8-((6-(ethyl-(2-methoxybenzyl)amino)hexanoyl)methylamino)octyl)methylamide [MeSH Supplementary Concept]
- 6-methyl-4-((2-oxopentadecanoyl)amino)heptanoic acid [MeSH Supplementary Concept]
- 6-methylbenzo(b)thiophene-2-carboxylic acid (1-(1-benzyl-4-(4-(tetrahydropyran-4-ylmethyl)piperazin-1-yl)butylcarbamoyl)cyclopentyl)amide [MeSH Supplementary Concept]
- 6-phenyl-(4-methylphenyl)-3(2H)-pyridazinon-2-propionamide [MeSH Supplementary Concept]
- 7'-(3',4'-dihydroxyphenyl)-N-((4-methoxyphenyl)ethyl)propenamide [MeSH Supplementary Concept]
- 7'-(4'-hydroxy,3'-methoxyphenyl)-N-((4-butylphenyl)ethyl)propenamide [MeSH Supplementary Concept]
- 7-fluoro-1,2-dihydro-3-oxo-N-(2,6-diflurophenyl)pyrido(1,2-alpha)benzimidazole-4-carboxamide [MeSH Supplementary Concept]
- 9-isopropyl-6-(4-methoxy-benzylamino)-9H-purine-2-carboxylic acid isopropylamide [MeSH Supplementary Concept]
- A 74273 [MeSH Supplementary Concept]
- A 87049 [MeSH Supplementary Concept]
- A-558693 [MeSH Supplementary Concept]
- AF 14049 [MeSH Supplementary Concept]
- AGN 211334 [MeSH Supplementary Concept]
- ALG-097111 [MeSH Supplementary Concept]
- ALT-946 [MeSH Supplementary Concept]
- AM 6201 [MeSH Supplementary Concept]
- AN7973 [MeSH Supplementary Concept]
- AT 61 [MeSH Supplementary Concept]
- AWD 12-281 [MeSH Supplementary Concept]
- AX 059 [MeSH Supplementary Concept]
- AX 115 [MeSH Supplementary Concept]
- AX 20017 [MeSH Supplementary Concept]
- BB 3437 [MeSH Supplementary Concept]
- BM 12.1179 [MeSH Supplementary Concept]
- BM 12.1200 [MeSH Supplementary Concept]
- BPAMD ligand [MeSH Supplementary Concept]
- Bang52 [MeSH Supplementary Concept]
- C-170 [MeSH Supplementary Concept]
- CAPCNC6 [MeSH Supplementary Concept]
- CCT251236 [MeSH Supplementary Concept]
- CF66I compound [MeSH Supplementary Concept]
- CGA 137053 [MeSH Supplementary Concept]
- CP 320626 [MeSH Supplementary Concept]
- CP 91149 [MeSH Supplementary Concept]
- CT 1166 [MeSH Supplementary Concept]
- CT 1746 [MeSH Supplementary Concept]
- DCZ3301 [MeSH Supplementary Concept]
- DDMS [MeSH Supplementary Concept]
- DL-3-hydroxy-3-phenyl pentanamide [MeSH Supplementary Concept]
- DODA 501 [MeSH Supplementary Concept]
- Docosahexaenoyl difluorodeoxycytidine [MeSH Supplementary Concept]
- EI 1511-3 [MeSH Supplementary Concept]
- EI 1511-5 [MeSH Supplementary Concept]
- EI 1625-2 [MeSH Supplementary Concept]
- ETH 1644 [MeSH Supplementary Concept]
- ETH 5282 [MeSH Supplementary Concept]
- Eltanexor [MeSH Supplementary Concept]
- FAAH inhibitor MCH1 [MeSH Supplementary Concept]
- FF-10101 [MeSH Supplementary Concept]
- FR 901277 [MeSH Supplementary Concept]
- GENZ 29155 [MeSH Supplementary Concept]
- GNE-987 [MeSH Supplementary Concept]
- H 224-45 [MeSH Supplementary Concept]
- H 409-22 [MeSH Supplementary Concept]
- HMR 279 [MeSH Supplementary Concept]
- HOE 17879 [MeSH Supplementary Concept]
- IC 202A [MeSH Supplementary Concept]
- IC 202B [MeSH Supplementary Concept]
- IC 202C [MeSH Supplementary Concept]
- KDAN 18 [MeSH Supplementary Concept]
- KNI 764 [MeSH Supplementary Concept]
- L 245976 [MeSH Supplementary Concept]
- L 739787 [MeSH Supplementary Concept]
- L 779976 [MeSH Supplementary Concept]
- L 817818 [MeSH Supplementary Concept]
- L-FDVDA [MeSH Supplementary Concept]
- L-N6-(1-iminoethyl)lysine-5-tetrazole-amide [MeSH Supplementary Concept]
- L796778 [MeSH Supplementary Concept]
- L803087 [MeSH Supplementary Concept]
- LB 71350 [MeSH Supplementary Concept]
- LFM A13 [MeSH Supplementary Concept]
- LG325 [MeSH Supplementary Concept]
- MAG 283 [MeSH Supplementary Concept]
- ME 3277 [MeSH Supplementary Concept]
- MI-1851 [MeSH Supplementary Concept]
- N'-(N-(3-hydroxydihydrobetulin28-oyl)-8-aminooctanoyl)-4-amino-3-hydroxy-6-methylheptanoic acid [MeSH Supplementary Concept]
- N(1)-heptadecanoyl-1,16-diamino-4,8,13-triazahexadecane [MeSH Supplementary Concept]
- N,N'-1,4-butanediyl-bis(6-hydroxy-hexanamide) [MeSH Supplementary Concept]
- N,N'-bis(1,5-dimethyl-2-phenyl-1,2-dihydro-3-oxopyrazol-4-yl) sebacamide [MeSH Supplementary Concept]
- N,N'-bis(2-(1H-imidazol-2-yl)ethyl)pentanediamide [MeSH Supplementary Concept]
- N,N'-bis(2-hydroxyethyl)-1,4,6,8-naphthalenediimide [MeSH Supplementary Concept]
- N,N'-bis(glycine-2- benzimidazolyl)hexanediamide [MeSH Supplementary Concept]
- N,N'-di(2,3-dihydroxypropyl)-1,4-naphthalenedipropanamide 1,4-endoperoxide [MeSH Supplementary Concept]
- N,N-bis(2-pyridylmethyl)amine-N-ethyl-2-pyridine-2-carboxamide [MeSH Supplementary Concept]
- N,N-di(2-ethylhexyl)isobutyramide [MeSH Supplementary Concept]
- N,N-di-n-propyl-(N1-methyl-2-(4'-nitrophenyl)indol-3-yl)glyoxylamide [MeSH Supplementary Concept]
- N,N-diethylcyclohexanepropanamide [MeSH Supplementary Concept]
- N,N-dimethylacetoacetamide [MeSH Supplementary Concept]
- N-((1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl)octanamide [MeSH Supplementary Concept]
- N-(-2-chloro-1-phenylethyl)-2-(4-phenyl-4,5-dihydrooxazol-2-yl)butyramide [MeSH Supplementary Concept]
- N-(1,3-dihydroxyisopropyl)-2-hexyl-3-oxodecanamide [MeSH Supplementary Concept]
- N-(1-((2-aminopyridin-6-yl)methyl)piperidin-4-yl) alpha-(3,3-difluorocyclopentyl)phenylethanamide [MeSH Supplementary Concept]
- N-(1-((6-fluoro-2-naphthyl)methyl)pyrrolidin-3-yl)-2-(1-((3-methyl-1-oxidopyridin-2-yl)carbonyl)piperidin-4-ylidene)acetamide [MeSH Supplementary Concept]
- N-(1-(2-(4-(2-methyl-3-(4-chlorophenyl)propionyl)-1-piperazinyl)-5-chlorophenyl)-3-methylbutyl)-3-(dimethylamino)propionamide [MeSH Supplementary Concept]
- N-(1-(3,5-difluorobenzyl)-2-hydroxy-4-isobutylcarbamoylpentyl)-N',N'-dipropylisophthalamide [MeSH Supplementary Concept]
- N-(1-(4-nitrophenyl)-1,3-dihydroxyprop-2-yl)tetradecanamide [MeSH Supplementary Concept]
- N-(1-azabicyclo(2.2.2)octan-3-yl)-8-chloro-2,6-methano-3,4,5,6-tetrahydro-2H-1-benzoxocin-10-carboxamide [MeSH Supplementary Concept]
- N-(1-carbamoylpropyl)-4-chlorobutyramide [MeSH Supplementary Concept]
- N-(1-ethyl-5-methanesulfonylamino-4,6-dimethylindolin-7-yl)-2,2-dimethylpropanamide [MeSH Supplementary Concept]
- N-(2,3,5-triazoyl)mycophenolic amide [MeSH Supplementary Concept]
- N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide [MeSH Supplementary Concept]
- N-(2-((4-propionyloxyphenyl)thio)ethyl) propionamide [MeSH Supplementary Concept]
- N-(2-(1-naphthyl)ethyl)cyclobutylcarboxamide [MeSH Supplementary Concept]
- N-(2-(2,3-dihydro-6-methoxy-1H-inden-1yl)ethyl)propionamide [MeSH Supplementary Concept]
- N-(2-(2-(4-chlorophenyl)-1,3-thiazol-4-yl)ethyl)butanamide [MeSH Supplementary Concept]
- N-(2-(2-(bromoacetoxy)-7-methoxynaphtyl)ethyl)-propionamide [MeSH Supplementary Concept]
- N-(2-(2-aminoethylamino)ethyl)picolinamide [MeSH Supplementary Concept]
- N-(2-(3-cyanophenyl)-3-(4-(2-fluoroethoxy)phenyl)-1-methylpropyl)-2-methyl-2-((5-methylpyridin-2-yl)oxy)propanamide [MeSH Supplementary Concept]
- N-(2-(3-cyanophenyl)-3-(4-(2-methoxy)phenyl)-1-methylpropyl)-2-(5-methyl-2-pyridyloxy)-2-methylpropanamide [MeSH Supplementary Concept]
- N-(2-cyanomethylsulfonylphenyl)acylamide [MeSH Supplementary Concept]
- N-(2-hydroxy-tert-butyl)(4-(4-(3-(trifluoromethyl)phenyl)imidazol-2-yl)cyclohexyl)carboxamide [MeSH Supplementary Concept]
- N-(2-hydroxyethyl)lactamide [MeSH Supplementary Concept]
- N-(2-hydroxyphenyl)-2-propylpentanamide [MeSH Supplementary Concept]
- N-(2-isobutyl-3-(N'-hydroxycarbonylamido)propanoyl)-O-methyltyrosinemethylamide [MeSH Supplementary Concept]
- N-(2-methylbenzylidene)-phenylglycine amide [MeSH Supplementary Concept]
- N-(2-pyrimidyl)butanamide [MeSH Supplementary Concept]
- N-(3',4',5'-trihydroxyl)-phenylethyl-4-hydroxyl-cinnamamide [MeSH Supplementary Concept]
- N-(3',4',5'-trihydroxyl)-phenylethyl-4-methoxy-cinnamamide [MeSH Supplementary Concept]
- N-(3'-hydroxyl-4'-methoxy)-phenylethyl-4-hydroxyl-cinnamamide [MeSH Supplementary Concept]
- N-(3,4,5 trimethoxybenzyl)-2-((3-(3,4,5-trimethoxybenzyl)-4(3H)-quinazolinon-2-yl)thio)propanamide [MeSH Supplementary Concept]
- N-(3,5-bis(trifluoromethyl)benzyl)-2-(4-fluorophenyl)-4-(4-phenylpiperidin-1-yl)butanamide [MeSH Supplementary Concept]
- N-(3-((1,4'-bipiperidin)-1'-yl)propyl)-6-(4-(4-methylpiperazin-1-yl)phenyl)picolinamide [MeSH Supplementary Concept]
- N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide [MeSH Supplementary Concept]
- N-(3-(dimethylamino)propyl)docosanamide [MeSH Supplementary Concept]
- N-(3-hydroxy-1-hydroxymethyl-3-phenylpropyl)dodecanamide [MeSH Supplementary Concept]
- N-(3-oxo-hexahydrocyclopenta(b)furan-3a-yl)acylamide [MeSH Supplementary Concept]
- N-(3-triethoxysilylpropyl)-6-(N-maleimido)-hexanamide [MeSH Supplementary Concept]
- N-(4-(4-azidobenzamido)butyl)-3-(2'-pyridyldithio)propionamide [MeSH Supplementary Concept]
- N-(4-(4-tert-butylphenyl)thiazol-2-yl)-N-propyl-2-cyano-3-hydroxy-2-butenamide [MeSH Supplementary Concept]
- N-(4-ethoyphenol)-2-hydroxy- acid amide [MeSH Supplementary Concept]
- N-(4-hydroxy-5-nitro-3-methoxybenzyl)nonanamide [MeSH Supplementary Concept]
- N-(4-phenylbutyl)-4-hydroxycinnamide [MeSH Supplementary Concept]
- N-(5-isopropyl-thiazol-2-yl)isobutyramide [MeSH Supplementary Concept]
- N-(7-(1-hydroxyethyl)-3-(4-isopropylphenyl)-4,6-dimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide [MeSH Supplementary Concept]
- N-(S)-2-heptyl (1R,2R)-2-(2,3-anthracenedicarboximido)cyclohexamide [MeSH Supplementary Concept]
- N-(aminocarbonyl)-2-ethyl-2-butenamide [MeSH Supplementary Concept]
- N-(isopropyl)propionamide [MeSH Supplementary Concept]
- N-(n-butyl) phosphorictriamide [MeSH Supplementary Concept]
- N-4'-((3'-trifluoromethoxy)phenoxy)benzyl 2-N-acetamido-3-methoxypropionamide [MeSH Supplementary Concept]
- N-acetyl-N'-methylamide [MeSH Supplementary Concept]
- N-benzyl-2,3-dimethoxypropionamide [MeSH Supplementary Concept]
- N-benzyl-N-hydroxy-5-phenylpentamide [MeSH Supplementary Concept]
- N-cyclohexanecarbonylpentadecylamine [MeSH Supplementary Concept]
- N-cyclopentyl-N-methyl-3-(4-amidrazonophenyl)-2-(2-naphthylsulfonylamino)-propionamide [MeSH Supplementary Concept]
- N-geranyl cyclopropylcarboxamide [MeSH Supplementary Concept]
- N-hydroxy-N-methyl 4-(2,3-bis-(4-methoxyphenyl)-thiophen-5-yl)butanamide [MeSH Supplementary Concept]
- N-isobutyl-(E, E, E, Z)-2,4,10,1 2-tetradecatetraen-8-ynamide [MeSH Supplementary Concept]
- N-isobutyl-11-(4-chlorophenyl)undeca-2,4,9-trienamide [MeSH Supplementary Concept]
- N-isobutyl-5-(3,4-methylenedioxyphenyl)-2,4-pentadienamine [MeSH Supplementary Concept]
- N-isobutyl-decanamide [MeSH Supplementary Concept]
- N-methyl 2,2,3,3-tetramethylcyclopropane carboxamide [MeSH Supplementary Concept]
- N-methyl-N-2-(methylsulfinyl)ethylpropionic acid amide [MeSH Supplementary Concept]
- N-methyl-N-trimethylsilylheptafluorobutyramide [MeSH Supplementary Concept]
- N-methyl-bis(heptafluorobutyramide) [MeSH Supplementary Concept]
- N-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide [MeSH Supplementary Concept]
- N-phenylpyrrolamide [MeSH Supplementary Concept]
- N1,N6-bis(2-hydroxy-1--indanyl)-2,5-bis(2,5-difluorobenzyloxy)-3,4-dihydroxyhexanediamide [MeSH Supplementary Concept]
- N1,N6-bis(2-hydroxy-1-indanyl)-2,5-bis(2,3-difluorobenzyloxy)-3,4-dihydroxyhexanediamide [MeSH Supplementary Concept]
- N1,N6-bis(hydroxy-1-indanyl)-3,4-dihydroxy-2,5-bis(2-phenylethyl)hexanediamide [MeSH Supplementary Concept]
- NOTA-PRGD2 [MeSH Supplementary Concept]
- NPC 15342 [MeSH Supplementary Concept]
- NPSR-QA1 compound [MeSH Supplementary Concept]
- NSC 644221 [MeSH Supplementary Concept]
- NU 1064 [MeSH Supplementary Concept]
- NW 1029 [MeSH Supplementary Concept]
- O-methyl-serine dodecylamide hydrochloride [MeSH Supplementary Concept]
- PMX30016 [MeSH Supplementary Concept]
- PNU 87407 [MeSH Supplementary Concept]
- PNU 88509 [MeSH Supplementary Concept]
- PR-amide [MeSH Supplementary Concept]
- PSMA-BCH [MeSH Supplementary Concept]
- R-4-(3-hydroxyphenyl)-N,N-7,8-tetramethyl-3,4-dihydroisoquinoline-2(1H)-carboxamide [MeSH Supplementary Concept]
- S 20642 [MeSH Supplementary Concept]
- S-3-(4-fluoro-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamid [MeSH Supplementary Concept]
- S-3-(4-fluorophenoxy)-2-hydroxy-2-methyl-N-(4-cyano-3-iodophenyl)-propionamide [MeSH Supplementary Concept]
- SAN 58035 [MeSH Supplementary Concept]
- SARS-CoV-2-IN-1 [MeSH Supplementary Concept]
- SB-568849 [MeSH Supplementary Concept]
- SC 41661A [MeSH Supplementary Concept]
- SK-7041 [MeSH Supplementary Concept]
- SM 20220 [MeSH Supplementary Concept]
- SMDC 256047 [MeSH Supplementary Concept]
- ST3913 [MeSH Supplementary Concept]
- STX17 inhibitor S670 [MeSH Supplementary Concept]
- T 0757 [MeSH Supplementary Concept]
- T 61 [MeSH Supplementary Concept]
- TAK 779 [MeSH Supplementary Concept]
- TEI 6620 [MeSH Supplementary Concept]
- TEI 8364 [MeSH Supplementary Concept]
- TIR-199 [MeSH Supplementary Concept]
- TP0438836 [MeSH Supplementary Concept]
- UCM1014 [MeSH Supplementary Concept]
- UR-DE257 [MeSH Supplementary Concept]
- Y 27632 [MeSH Supplementary Concept]
- Z-505 hydrochloride [MeSH Supplementary Concept]
- ZINC09315614 [MeSH Supplementary Concept]
- ZINC58368839 [MeSH Supplementary Concept]
- ZINC67825876 [MeSH Supplementary Concept]
- ZM226600 [MeSH Supplementary Concept]
- abrusamide H [MeSH Supplementary Concept]
- adda precursor [MeSH Supplementary Concept]
- adipamide [MeSH Supplementary Concept]
- aegeline [MeSH Supplementary Concept]
- aglaiamide A [MeSH Supplementary Concept]
- aglaiamide B [MeSH Supplementary Concept]
- aglaidithioduline [MeSH Supplementary Concept]
- aglaiduline [MeSH Supplementary Concept]
- aglaithioduline [MeSH Supplementary Concept]
- aliskiren [MeSH Supplementary Concept]
- alpaha-cyano-beta-hydroxy-N-(4-(trifluoromethyl)phenyl)-3-(4-(trifluoromethyl)phenyl)propenamide [MeSH Supplementary Concept]
- amathamide A [MeSH Supplementary Concept]
- amidozinc [MeSH Supplementary Concept]
- ammosamide A [MeSH Supplementary Concept]
- ammosamide B [MeSH Supplementary Concept]
- ammosamide D [MeSH Supplementary Concept]
- annimycin [MeSH Supplementary Concept]
- aquaramide [MeSH Supplementary Concept]
- aspergilliamide B [MeSH Supplementary Concept]
- autantiamide acetate [MeSH Supplementary Concept]
- aza-(6)-gingerol [MeSH Supplementary Concept]
- basiliskamide B [MeSH Supplementary Concept]
- beta-(4-hydroxyphenyl)lactic acid farnesyl amide [MeSH Supplementary Concept]
- beta-D-glucopyranosyl bismethoxyphosphoramidate [MeSH Supplementary Concept]
- beta-Gal-Py-gamma-Py-Ind [MeSH Supplementary Concept]
- beta-ketoamide [MeSH Supplementary Concept]
- bictegravir [MeSH Supplementary Concept]
- bictegravir glucuronide [MeSH Supplementary Concept]
- bipolamide B [MeSH Supplementary Concept]
- bis(2-(2-octenoylamino)ethyl)disulfide [MeSH Supplementary Concept]
- bis(2-chalcogenoethyl)amide [MeSH Supplementary Concept]
- bis(3,5-di-tert-butyl-2-phenolate)amide [MeSH Supplementary Concept]
- bis(4-aminophenyl)amide [MeSH Supplementary Concept]
- bis-2-ethylhexyl succinamic acid [MeSH Supplementary Concept]
- bistellettazine A [MeSH Supplementary Concept]
- bistellettazine B [MeSH Supplementary Concept]
- bistellettazine C [MeSH Supplementary Concept]
- bistellettazole A [MeSH Supplementary Concept]
- brachystamide-C [MeSH Supplementary Concept]
- brachystamide-D [MeSH Supplementary Concept]
- brachystamide-E [MeSH Supplementary Concept]
- brefelamide [MeSH Supplementary Concept]
- breynivosamide A [MeSH Supplementary Concept]
- butoctamide [MeSH Supplementary Concept]
- butoctamide succinate [MeSH Supplementary Concept]
- butyramide [MeSH Supplementary Concept]
- callyspongamide A [MeSH Supplementary Concept]
- caproamide [MeSH Supplementary Concept]
- caproctamine [MeSH Supplementary Concept]
- carpropamid [MeSH Supplementary Concept]
- cassipoureamide-A [MeSH Supplementary Concept]
- cassipoureamide-B [MeSH Supplementary Concept]
- chloroamide S-330 [MeSH Supplementary Concept]
- chrysamide A [MeSH Supplementary Concept]
- chrysamide B [MeSH Supplementary Concept]
- chrysamide C [MeSH Supplementary Concept]
- cis-2,3-epoxy-4-oxododecanamide [MeSH Supplementary Concept]
- clauemaramide A [MeSH Supplementary Concept]
- clauemaramide B [MeSH Supplementary Concept]
- crocacin A [MeSH Supplementary Concept]
- crocacin B [MeSH Supplementary Concept]
- crocacin C [MeSH Supplementary Concept]
- crocacin D [MeSH Supplementary Concept]
- crotamide A [MeSH Supplementary Concept]
- crotamide B [MeSH Supplementary Concept]
- cyclo(2,2-dimethylalanyl-2-hydroxy-4-(methylpentanoyl)-5-hydroxy-6-(3-phenyloxiranyl)-2-heptenoyl-3-chloro-4-(dimethylamino)phenylalanyl) [MeSH Supplementary Concept]
- cyclopentane dicarboxamide [MeSH Supplementary Concept]
- cyclopropanecarboxamide [MeSH Supplementary Concept]
- cylindramide [MeSH Supplementary Concept]
- cystobactamid 861-2 [MeSH Supplementary Concept]
- dalcetrapib [MeSH Supplementary Concept]
- dehydrothalebanin B [MeSH Supplementary Concept]
- diamidopyridine [MeSH Supplementary Concept]
- diazotrifluoropropionamide [MeSH Supplementary Concept]
- diethyl-N-dodecylphosphoramidate [MeSH Supplementary Concept]
- dihydroxyphenylvaleramide [MeSH Supplementary Concept]
- dimethyl-N,N'-oxalamidodiethanoate [MeSH Supplementary Concept]
- dioxaoctanediamide [MeSH Supplementary Concept]
- diphenylacetylene-4,4'-dicarboxamide [MeSH Supplementary Concept]
- dodeca-2Z,4E-diene-8,10-diynoic acid isobutylamide [MeSH Supplementary Concept]
- dopastin [MeSH Supplementary Concept]
- elasticamide [MeSH Supplementary Concept]
- elinafide [MeSH Supplementary Concept]
- embutramide [MeSH Supplementary Concept]
- entadamide B [MeSH Supplementary Concept]
- eponemycin [MeSH Supplementary Concept]
- epopromycin A [MeSH Supplementary Concept]
- epopromycin B [MeSH Supplementary Concept]
- epostatin [MeSH Supplementary Concept]
- favipiravir [MeSH Supplementary Concept]
- fluridil [MeSH Supplementary Concept]
- fluxapyroxad [MeSH Supplementary Concept]
- frankiamide [MeSH Supplementary Concept]
- fumaramide [MeSH Supplementary Concept]
- gamma-AApeptide [MeSH Supplementary Concept]
- ganfort [MeSH Supplementary Concept]
- ganglioside GD3 amide congener [MeSH Supplementary Concept]
- glycine alpha-ketoamide [MeSH Supplementary Concept]
- grazoprevir [MeSH Supplementary Concept]
- grenadamide [MeSH Supplementary Concept]
- heitziamide A [MeSH Supplementary Concept]
- heitziamide B [MeSH Supplementary Concept]
- heliotropiumide A [MeSH Supplementary Concept]
- heliotropiumide B [MeSH Supplementary Concept]
- hermitamide A [MeSH Supplementary Concept]
- hermitamide B [MeSH Supplementary Concept]
- icenticaftor [MeSH Supplementary Concept]
- isobutyramide [MeSH Supplementary Concept]
- isomalyngamide A [MeSH Supplementary Concept]
- isomalyngamide B [MeSH Supplementary Concept]
- isovaleramide [MeSH Supplementary Concept]
- jamaicamide A [MeSH Supplementary Concept]
- jamaicamide B [MeSH Supplementary Concept]
- jamaicamide C [MeSH Supplementary Concept]
- kanamienamide [MeSH Supplementary Concept]
- kaousine [MeSH Supplementary Concept]
- kemamide E 180 [MeSH Supplementary Concept]
- kemamide S [MeSH Supplementary Concept]
- kunstleramide [MeSH Supplementary Concept]
- lactamide [MeSH Supplementary Concept]
- lansamide-2 [MeSH Supplementary Concept]
- lorneamide A [MeSH Supplementary Concept]
- lorneamide B [MeSH Supplementary Concept]
- lyciumamide A [MeSH Supplementary Concept]
- malyngamide Q [MeSH Supplementary Concept]
- malyngamide R [MeSH Supplementary Concept]
- malyngamide X [MeSH Supplementary Concept]
- mandipropamid [MeSH Supplementary Concept]
- maoxianamide A [MeSH Supplementary Concept]
- maoxianamide B [MeSH Supplementary Concept]
- methyl (Z)-3-(3,4-dihydroxyphenyl)-2-formamidoacrylate [MeSH Supplementary Concept]
- methyl neodecanamide [MeSH Supplementary Concept]
- methyl phenylglycine amide [MeSH Supplementary Concept]
- methylgerambullin [MeSH Supplementary Concept]
- methylisogermabullone [MeSH Supplementary Concept]
- methylterephthalamide [MeSH Supplementary Concept]
- moiramide B [MeSH Supplementary Concept]
- ostarine [MeSH Supplementary Concept]
- p97 inhibitor fl-18 [MeSH Supplementary Concept]
- palmidrol [MeSH Supplementary Concept]
- pestalotiopamide E [MeSH Supplementary Concept]
- phosphoramidic acid [MeSH Supplementary Concept]
- picolinamide [MeSH Supplementary Concept]
- piperchabamide F [MeSH Supplementary Concept]
- piperlongimin A [MeSH Supplementary Concept]
- podocarpamide [MeSH Supplementary Concept]
- poly(N-vinylformamide) [MeSH Supplementary Concept]
- poly(m-phenyleneisophthalamide) [MeSH Supplementary Concept]
- propionamide [MeSH Supplementary Concept]
- pyramidatine [MeSH Supplementary Concept]
- pyrazofurin [MeSH Supplementary Concept]
- pyridine-2-carboxylic acid thiazol-2-ylamide [MeSH Supplementary Concept]
- refrofractamide A [MeSH Supplementary Concept]
- retrofractamide A [MeSH Supplementary Concept]
- retrofractamide C [MeSH Supplementary Concept]
- retrofractamide-D [MeSH Supplementary Concept]
- salaramide A [MeSH Supplementary Concept]
- salaramide B [MeSH Supplementary Concept]
- saliphenylhalamide [MeSH Supplementary Concept]
- salisomide [MeSH Supplementary Concept]
- sanshool [MeSH Supplementary Concept]
- sch 725424 [MeSH Supplementary Concept]
- sch 725428 [MeSH Supplementary Concept]
- scyphostatin [MeSH Supplementary Concept]
- sec-butyl-propylacetamide [MeSH Supplementary Concept]
- sobustiamide [MeSH Supplementary Concept]
- submultinamide A [MeSH Supplementary Concept]
- succinamide [MeSH Supplementary Concept]
- sulphadicramide [MeSH Supplementary Concept]
- thiazolebisamide [MeSH Supplementary Concept]
- turbinamide [MeSH Supplementary Concept]
- uvariadiamide [MeSH Supplementary Concept]
- valnoctamide [MeSH Supplementary Concept]
- vulnibactin [MeSH Supplementary Concept]
- xylaramide [MeSH Supplementary Concept]
- yakushinamide A [MeSH Supplementary Concept]
- yakushinamide B [MeSH Supplementary Concept]
- zeneca ZD 6169 [MeSH Supplementary Concept]
- zoxamide [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Amide (substance) [SNOMED CT concept]
- amide, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients